You are here

Nat Genet DOI:10.1038/s41588-022-01110-2

Bidirectional genome-wide CRISPR screens reveal host factors regulating SARS-CoV-2, MERS-CoV and seasonal HCoVs.

Publication TypeJournal Article
Year of Publication2022
AuthorsRebendenne, A, Roy, P, Bonaventure, B, Valadão, ALuiza Chav, Desmarets, L, Arnaud-Arnould, M, Rouillé, Y, Tauziet, M, Giovannini, D, Touhami, J, Lee, Y, DeWeirdt, P, Hegde, M, Urbach, S, Koulali, KEl, de Gracia, FGarcia, McKellar, J, Dubuisson, J, Wencker, M, Belouzard, S, Moncorgé, O, Doench, JG, Goujon, C
JournalNat Genet
Date Published2022 Jul 25
ISSN1546-1718
Abstract

CRISPR knockout (KO) screens have identified host factors regulating severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) replication. Here, we conducted a meta-analysis of these screens, which showed a high level of cell-type specificity of the identified hits, highlighting the necessity of additional models to uncover the full landscape of host factors. Thus, we performed genome-wide KO and activation screens in Calu-3 lung cells and KO screens in Caco-2 colorectal cells, followed by secondary screens in four human cell lines. This revealed host-dependency factors, including AP1G1 adaptin and ATP8B1 flippase, as well as inhibitors, including mucins. Interestingly, some of the identified genes also modulate Middle East respiratory syndrome coronavirus (MERS-CoV) and seasonal human coronavirus (HCoV) (HCoV-NL63 and HCoV-229E) replication. Moreover, most genes had an impact on viral entry, with AP1G1 likely regulating TMPRSS2 activity at the plasma membrane. These results demonstrate the value of multiple cell models and perturbational modalities for understanding SARS-CoV-2 replication and provide a list of potential targets for therapeutic interventions.

DOI10.1038/s41588-022-01110-2
Pubmed

https://www.ncbi.nlm.nih.gov/pubmed/35879413?dopt=Abstract

Alternate JournalNat Genet
PubMed ID35879413
Grant List759226 / / EC | EU Framework Programme for Research and Innovation H2020 | H2020 Priority Excellent Science | H2020 European Research Council (H2020 Excellent Science - European Research Council) /
ANR-20-COV6-0001 / / Agence Nationale de la Recherche (French National Research Agency) /
R21AI157835 / / U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases (NIAID) /